Simple Summary The high lethality of colorectal cancer (CRC) is anticipated to continue in
the following decades. Early-stage CRC is entirely treatable with surgery and adjuvant …

This document is a focused update to the 2017 colorectal cancer (CRC) screening
recommendations from the US Multi-Society Task Force on Colorectal Cancer, which …

Globally, colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the
second leading cause of cancer death. Arising through three major pathways, including …

Abstract In the United States, colorectal cancer (CRC) is the fourth most common cancer
diagnosed among adults and the second leading cause of death from cancer. For this …

The detection and removal of precancerous polyps via colonoscopy is the gold standard for
the prevention of colon cancer. However, the detection rate of adenomatous polyps can vary …

Background The causative factors for the recent increase in early-onset colorectal cancer
(EO-CRC) incidence are unknown. We sought to determine if early-onset disease is …

Objective Screening colonoscopy's effectiveness in reducing colorectal cancer mortality risk
in community populations is unclear, particularly for right-colon cancers, leading to …

This article has an accompanying continuing medical education activity on page e19.
Learning Objective: Upon completion of this exam, successful learners will recognize the …

Abstract In the United States, colorectal cancer (CRC) is the third most common and second
most lethal cancer. More than one-tenth of CRC cases (11% of colon cancers and 18% of …

The “serrated neoplastic pathway” describes the progression of serrated polyps, including
sessile serrated adenomas and traditional serrated adenomas, to colorectal cancer. The …